Abstract
Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
- Received September 4, 2014.
- Accepted November 10, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Editor's Choice – Lifespan analysis of phenotypes in three mouse models of Down syndrome
A comparison of three mouse models of Down syndrome by Diana W. Bianchi and co-workers reveals widespread and unexpected fundamental differences in behavioural, gene expression and brain development phenotypes.
Find out more about the story behind this Editor's Choice article in an interview with first author Nadine M. Aziz.
Review – Hidden features: exploring the non-canonical functions of metabolic enzymes
A new Review from Peiwei Huangyang and M. Celeste Simon, part of our upcoming special issue on Cancer metabolism, summarizes recent findings about multifaceted metabolic enzymes with non-canonical activities outside their core biochemical functions, and how they may provide new therapeutic strategies for cancers.
Featured article – Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
Gustav Steinhoff and colleagues report that cardiac mesenchymal stem cells respond early to myocardial infarction, and that their regenerative capacity is directly upregulated by optimized stimulation of the heart through epicardial erythropoietin delivery.
First Person interviews
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with first authors Nadine Aziz, Tingting Sui, Brian Lu, Hannah Gordon, Theresa Kisko, Francisco Javier García-Rodríguez and Laura Schultz.
Why should you publish your next paper in DMM?
DMM aims to promote human health by encouraging collaboration between basic and clinical researchers, covering a diverse range of diseases, approaches and models. Our Editors are all active researchers in the field – your peers, colleagues and mentors, who know how much work has gone into every paper. Recently, we have introduced format-free submission, and we accept peer review reports from other journals, making submission as easy as possible for our authors. Send us your next great paper – publish with us and you'll be in good company.
preLights – Using zebrafish to model the effects of candidate disease gene variants in complex human genetic disorders
Highlighted by Hannah Brunsdon, a recent preprint from Lisa Maves and co-workers describes the first example of modelling a complex genetic disorder in zebrafish, and demonstrates that a human candidate disease variant of unknown significance acts as a modifier gene for congenital heart defects.